Based on these data and the published literature, we believe A20 and B78 tumor models have similar, baseline levels of these CpG responsive immune subpopulations (B78 macrophage frequency ~25% of CD45+, B78 DC frequency ~2% of CD45+ vs A20 macrophage frequency ~30% of CD45+, A20 DC frequency ~1-2% of CD45+) (46). Here, PTPRC is linked to neoplasm.